Expression and Assembly of Procoagulant Complexes by Human Pleural Mesothelial Cells

Summary

Many pleural diseases involve fibrin deposition within the pleural cavity, an event that necessarily involves the mesothelium. This study of human pleural mesothelial cells (HPMC) was designed to determine how the mesothelium initiates and sustains the coagulation process. We used functional assays for activation of both factor X and prothrombin to examine expression and assembly of procoagulant activity by human pleural mesothelial cells in culture. The rates of factor Xa and thrombin formation were calcium-dependent. The rate of factor Xa formation in the presence of added factor VII increased in a concentration-dependent manner, suggesting that tissue factor is the primary procoagulant associated with HPMC. The fact that direct binding of radioiodinated factor Vila to HPMC was specific, concentration-dependent and saturable confirms that tissue factor is expressed on the cell surface. The rate of thrombin formation increased with factor Xa concentration, and the rate was 5-, 6-fold higher in presence of added factor Va indicating that HPMC support expression of prothrombinase activity. Further, direct binding of radioiodinated factor Xa to HPMC was specific, concentration-dependent and saturable, confirming that the cells support the assembly of the prothrombinase complex.

• References

• 1 Triplett DA. The Extrinsic System. Clin Lab Med 1984; 4: 221-244
• 2 Kaplan AP, Silverberg M, Dunn IT, Ghehebrehiwat B. Interaction of the clotting, kinin forming complement and fibrinolytic pathways in inflammation. Annals NY Acad Sci 1982; 389: 25-38
• 3 Brown LF, Dvorak AM, Dvorak HF. Leaky vessels, fibrin deposition and fibrosis: A sequence of events common to solid tumors and to many other types of disease. Am Rev Respir Dis 1989; 140: 1104-1107
• 4 Dvorak HF. Tumors: wounds that do not heal. N Engl J Med 1982; 315: 1650-1659
• 5 Senior RM, Skodgen WF, Griffen GL, Wilner GD. Effects of fibrinogen derivatives upon the inflammatory response. J Clin Invest 1986; 77: 1014-1019
• 6 Bignon J, Gee JBL, Pleural fibrogensis. In: The pleura in health and disease Chretien J, Bignon J, Hirsch A. (eds) NY: Marcel Dekker 1985; 417-443
• 7 Idell S, Girard W, Koenig KB, McLarty J, Fair DS. Abnormalities of pathways of fibrin turnover in the pleural space. Am Rev Respir Dis 1991; 144: 187-194
• 8 Rodgers GM, Greenberg CS, Shuman MA. Characterization of the effects of cultured vascular cells on the activation of blood coagulation. Blood 1983; 61: 1155-62
• 9 Tracy PB, Eide LL, Mann KG. Human prothrombinase complex assembly and function on isolated peripheral blood cell populations. J Biol Chem 1985; 260: 2119-24
• 10 Miletich JP, Jackson CM, Majerus PW. Properties of the factor Xa binding site on human platelets. J Biol Chem 1978; 253: 6908-6916
• 11 Fair DS. Quantitation of Factor VII in the plasma of normal and warfarin-treated individuals by radioimmunoassay. Blood 1983; 62: 784-791
• 12 Fair DS, Plow EF, Edgington TS. Combined functional and immunological analysis of normal and abnormal human Factor X. J. Clin Invest 1979; 64: 884-894
• 13 Kisiel W, Hermodson MA, Davie EW. Factor X activating enzyme from Russell’s viper venom. Isloation and characterization. Biochemistry 1983; 15: 4901-4906
• 14 Dahlback B. Human coagulation factor V purification and thrombin-catalysed activation. J Clin Invest 1980; 66: 583-591
• 15 Nesheim ME, Myrmel KH, Hibbard L, Mann KG. Isolation and characterization of single ehain buvine factor V. J Biol Chem 1979; 254: 508-517
• 16 Schwartz BS, Levy GA, Curtiss LK, Fair DS, Edgington TS. Plasma lipoprotein induction of cellular procoagulant activity in vitro 1. Two procoagulant activities are produced by peripheral blood mononuclear cells. J Clin Invest 1981; 67: 1650-1658
• 17 Lundblad RL, Kingdon HS, Mann KG. Meth Enzymol. (; 45). 1 1976: 56-176 Academic Press Inc; New York:
• 18 Higgins HL, Mann KG. The interaction of bovine fae.tnr V and factor V derived peptides with phospholipid vesicles. J Biol Chem 1983; 258: 6503-8
• 19 Idell S, Zweib C, Kumar A, Koenig KB, Johnson AR. Pathways of fibrin turnover of human pleural mesothelial cells in vitro. Am J Resp Cell Mol Biol 1992; 7: 414-426
• 20 Wu YJ, Parker LM, Binder NE, Beckett MA, Sinard JH, Thomas-Griffiths C, Rheinwald JG. The mesothelial keratins: a new family of cytoskeletal proteins identified in cultured mesothelial cells and non-keratinizing epithe-lia. Cell 1982; 31: 693-703
• 21 Fraker PJ, Speck JC Jr. Protein and cell membrane iodinations with a sparingly soluble chloroamide, l, 3,4,6-tetrachloro-3a, 6a-diphrenylglycoluril. Biochem Res Commun 1978; 80: 849-857
• 22 Kumar A, Blumenthal DK, Fair DS. Identification of molecular recognition site on factor VII which mediates its assembly and function in the extrinsic pathway activation complex. J Biol Chem 1991; 266: 915-921
• 23 Chattopadhyay A, Fair DS. Molecular recognition in the activation of human blood coagulation factor X. J Biol Chem 1989; 264: 1103-4
• 24 Stern DM, Drillings M, Kisiel W, Nossel HL, Hurlet-Jensen A, La Gamma KS, Owen J. Binding of factors IX and IXa to cultured vascular endothelial cells. Proc Natl Acad Sci USA 1983; 80: 4119-23
• 25 Rodgers GM, Shuman M. A characterization of the interaction between factor Xa and bovine arotic endothelial cells. Biochem Biophys Acta 1988; 844: 320-9
• 26 Tracy PB, Mann KG. Prothrombinase complex on the platelet surface is mediated through the 74,000-dalton component of factor Va. Proc Natl Acad Sci USA 1983; 80: 2380-4
• 27 Rao VM, Rapaport SI, Lorenzi M. Enhancement of umbilical vein endothelial cells of factor Xa catalyzed activation of factor VII. Blood 1988; 71: 791-796
• 28 Sakai T, Kisiel W. Binding of human factors X and Xa to HepG2 and J82 human tumor cell lines. J Biul Chem 1990; 265: 9105-9113
• 29 Wyshock EG, Idell S, Colman SW. The contribution of factor V to the coagulant property of pleural fluids. J Lab Clin Med 1992; 120: 726-734